Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

FDA-approved treatments for spinal muscular atrophy differ in their mechanisms of action, safety profiles, and administration ...

DelveInsight's "TIBSOVO Market Size, Forecast, and Market Insight Report" highlights the details around TIBSOVO, the first ...

Engine Biosciences (Engine), announced a new partnership with the Experimental Drug Development Centre (EDDC), Singapore's ...

Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

This marks the first-ever collaboration between Engine Biosciences and Experimental Drug Development Centre (EDDC), Singapore ...

Bayer today showcased significant advancements in its pharmaceutical growth strategy and pipeline at its recent annual Pharma ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.